Europe Wound Care Market Size, Share & Industry Analysis, By Type (Advanced Wound Dressings, {Antimicrobial Dressings, Alginate Dressings, Foam Dressings, Hydrocolloid Dressings, and Others}, Traditional Wound Care Products, Negative Pressure Wound Therapy, Bioactives {Biological Skin Equivalents, Growth Factors, and Others}, and Others), By Application (Chronic Wounds {Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others} and Acute Wounds {Surgical Wounds and Burns}), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Regional Forecast, 2023-2030

Europe is the second largest region in the global wound care market. It is projected to register a CAGR of 6.3% during the forecast period. The global market is projected to grow from USD 18.51 billion in 2022 to USD 30.04 billion by 2030.

The rising demand for wound care products owing to the growing burden of various wounds, such as diabetic foot ulcers, pressure ulcers, leg ulcers, and others in the region has prompted the key manufacturers to increase their R&D investment to introduce novel products in the market. To cite an instance, in June 2022, Smith & Nephew invested USD 100 million to open a new R&D and manufacturing facility in the U.K. The R&D facility was set up to increase the production of advanced wound management products to cater to the rising demand.

Similar efforts from other key players is expected to promote the Europe wound care market growth in the upcoming years. Furthermore, the growing number of surgical procedures, increasing incidence of diabetes, and rising percentage of the geriatric population may also drive the Europe wound care market share.

This report on this market covers the following countries/regions – the U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe.

LATEST TRENDS

Shifting Preference Toward Bioactive Wound Care Products to Aid Market Growth

At present, there is an emerging interest toward bioactive wound care products owing to the advantages associated with them. These products deliver various bioactive agents comprising vitamins, antibacterial agents, and growth factors to accelerate the wound healing process. Moreover, companies are shifting their focus to developing these advanced wound treatment products for managing various wounds efficiently.

• For instance, in February 2021, Axio Biosolutions received the CE mark approval for its next-generation wound care product, “MaxioCel”. The product is a bioactive microfiber intended to accelerate wound healing through quick granulation.

DRIVING FACTORS

Rising Cases of Chronic and Acute Wounds to Augment Market Progress

The market in the region is witnessing lucrative growth owing to the rising prevalence of various chronic wounds. Some of these wounds, such as diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others, have become one of the major health complications among the geriatric population suffering from various comorbidities.

• According to the German Diabetes Association’s 2020 data, the annual incidence of acute diabetic foot syndrome in Germany was about 2% of the diabetic population.

Thus, the rising burden of such wounds among the population is anticipated to raise the demand for wound treatment products.

RESTRAINING FACTORS

Request a Free sample to learn more about this report.

High Cost of Treatment and Limitations Associated with Wound Dressing to Impede Market Growth

Despite the approval and launch of new wound care products, some of the disadvantages associated with these products are anticipated to limit their adoption. For instance, hydrocolloid dressings prevent dirt and debris from entering the affected area. However, they are not helpful for deep infected wounds as they cannot absorb blood or bacterial infection. Furthermore, Negative Pressure Wound Therapy (NPWT) is helpful in extracting fluids from various wounds but might cause skin irritation, fistulas, and increase the risk of bleeding in patients using anticoagulants.

In addition, the cost of wound care is an increasing burden on European countries owing to the high cost of treatment. Patients suffering from chronic and acute wounds usually suffer from multiple comorbidities, which complicate and slow down the wound healing process, thus making it costly.

• For instance, according to a research article published in NCBI in 2022, the mean annual cost of treatment of venous leg ulcer in Germany is about USD 8,220.2 and arterial ulcer is USD 12,191.7, with higher cost being incurred among the female population.

KEY INDUSTRY PLAYERS

In terms of the competitive landscape, Smith & Nephew, ConvaTec Group PLC, and Mölnlycke Health Care AB are the key players in this market. The availability of a strong product portfolio, strong foothold in the region, increase in investments, and launch of new products by these companies are expected to contribute to their market share.

• For instance, in December 2020, Mölnlycke Health Care AB launched a distribution center in the U.K. and strengthened its supply chain network. Through this, the company offered easy access to its quality products.

Other prominent players, such as Paul Hartmann AG and Coloplast A/S are also leading the market due to their strategic inorganic activities, such as collaborations, partnerships, new product launches, and establishment of new manufacturing facilities to strengthen their market positions. Such factors are likely to boost the market growth over the forecast period.

LIST OF KEY COMPANIES PROFILED:

• Coloplast A/S (Denmark)


• Paul Hartmann AG (Germany)


• Smith & Nephew (U.K.)


• ConvaTec Group PLC (U.K.)


• Mölnlycke Health Care AB (Sweden)


• B. Braun Melsungen AG (Germany)


• Medtronic (Ireland)


• Integra Lifesciences (U.S.)


• 3M (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• May 2022: Winner Medical, an advanced wound care dressing manufacturer, launched various wound management solutions, such as transparent film dressings, bordered silicone foam dressings, CMC dressings, and other products in France.


• February 2021: DEBx Medical received the European Commission’s approval for Debrichem, a chemical wound debridement for the treatment of chronic or necrotic wounds.


• April 2021: Mölnlycke Health Care AB partnered with Kinaxis Inc. to transform its medical supply chain to meet rising customer demands.

REPORT COVERAGE

To gain extensive insights into the market, Request for Customization

The market report provides qualitative and quantitative insights on the market and a detailed analysis of the Europe market size & growth rate for all possible segments in the market. Along with the regional market’s forecast, the research report provides an elaborative analysis of the market dynamics and competitive landscape. Various key insights presented in the report are an overview of the prevalence of various chronic diseases in the region, new product launches, key industry developments – mergers, acquisitions & partnerships, and the impact of COVID-19 on the market.

Report Scope & Segmentation